November 06, 2022
October 18, 2022
November 01, 2022
April 23, 2024
The coronary stent market size was valued at USD 8.99 billion in 2023 and is anticipated to reach USD 12.51 billion by 2032, registering a significant growth with a 3.6% of CAGR (2024-2032). Report Highlights: Drug-eluting stents (DES) dominate...
April 19, 2024
The Ventricular Assist Device (VAD) market size was valued at USD 1.59 billion in 2023 and is anticipated to elevate USD 3.08 billion by 2032, registering a significant growth with a 7.1% CAGR (2024-2032). Report Highlights: LVAD (Left Ventricu...
April 17, 2024
The molecular diagnostics market size was valued at USD 15.42 billion in 2023 and is anticipated to uplift to USD 25.27 billion by 2032 registering a significant growth with a 5.3% CAGR (2024-2032). Report Highlights: Instruments and systems ex...
April 15, 2024
The inflammatory bowel disease treatment market size is estimated to grow from USD 19.91 billion in 2023 to reach around USD 33.19 billion by 2032, registering at a CAGR of 5.5% from 2024 to 2032. Report Highlights: Crohn’s disease by dis...
April 12, 2024
The musculoskeletal disorders treatment market size was valued at USD 186.02 billion in 2023 and is expected to reach USD 326.26 billion by 2032. Projected growth indicates a CAGR of 6.0% over the forecast period of 2024 - 2032. Report Highlights:...
April 11, 2024
The antipsychotic drugs market size was estimated at USD 18.04 billion in 2023 is to anticipate around USD 37.40 billion by 2032, increasing at a CAGR of 7.8% between 2024 and 2032. Report Highlights: Second-generation antipsychotic drugs domin...
April 10, 2024
The liver cancer drugs market size was valued at USD 2.67 billion in 2023 and is projected to reach USD 9.94 billion by 2032, registering a CAGR of 14.2% from 2024 to 2032. Report Highlights: Targeted therapies contributed to the largest market...
April 05, 2024
The anxiety disorders treatment market size achieved a value of USD 11.49 billion in 2023 and is anticipated to reach USD 15.90 billion by 2032. Projections suggest a compound annual growth rate (CAGR) of 3.6% from 2024 to 2032. Report Highlights:...
April 04, 2024
The epilepsy drugs market size achieved a value of USD 9.50 billion in 2023 and is anticipated to reach USD 15.16 billion by 2032. Projections suggest a compound annual growth rate (CAGR) of 5.1% for the period of 2024 to 2032. Report Highlights: ...
April 03, 2024
The spinal cord injury treatment market size achieved a value of USD 7.13 billion in 2023 and is anticipated to reach USD 11.00 billion by 2032. Projections suggest a compound annual growth rate (CAGR) of 4.8% for the period of 2024 to 2032. Repor...